Regenerative Medicine

Latest Headlines

Latest Headlines

Japan's JCR, Terumo gain PAFSC nods for regenerative medicine firsts under new law

Japan's JCR Pharmaceuticals has received a nod for JR-031, a human allogeneic mesenchymal stem cell-based regenerative medicine product, from the Pharmaceutical Affairs and Food Sanitation Council's committee on regenerative medicine, the company said in a release.

Stem cell laws in Japan a magnet for research, Nikkei says

Japan is building upon efforts last year to boost its standing as a regenerative medicine research hub with Prime Minister Shinzo Abe recently highlighting the field as key to the country's plans to revitalize the economy.

Japan's CiRA hopes for iPS cell clinical work as early as this year with stockpile cost advantage

Japan's Center for iPS Cell Research Application (CiRA) of Kyoto University hopes to ramp up clinical tests starting this or early next year with unspecified clinical research projects aimed at finding possible cures for various diseases as academic, clinical and company efforts merge, Nikkei Asian Review reports.

South Korea's GemVax Tech takes major stake in Swedish biotech NovaHep

South Korea's GemVax Technology picked up a 42% stake in Sweden-based NovaHep, a biotechnology company working on regenerative medicine in reconstructive surgery or for toxicity and biocompatibility studies, taking control of the company which has been seeking new equity since late last year.

Japan, S. Korea hospitals ink clinical pact on regenerative medicine

The operators of a pair of private hospital networks, one in Japan and the other in South Korea, signed a memorandum of understanding to cooperate on research into regenerative medicine, the work ranging from education activities to clinical applications.

Fujifilm Holdings goes big into stem cell manufacturing with $307 million Cellular Dynamics offer

Japan's Fujifilm Holdings will pay $307 million to buy all outstanding shares of NASDAQ-listed Cellular Dynamics International in a deal with will further expand its reach into regenerative medicine research.

Human intestinal organoids grown in mice could help personalize treatments

Researchers have grown human intestinal tissue from pluripotent stem cells and transplanted the living tissue into mice. These so-called organoids could provide a more accurate model for testing drugs designed to work on the intestines as well as help generate intestinal tissue for new treatments.

Stem cell treatment strengthens leg muscles in mice

Mesenchymal stem cells may eventually be able to grow and strengthen muscles in humans, according to researchers at the University of Illinois. In mice, an injection of such stem cells helped rejuvenate skeletal muscle after exercise.

Technique regrows corneas in mice from adult human stem cells

Researchers have figured out a way to identify stem cells in tissue from deceased human donors and use them to regrow anatomically correct, fully functional human corneas in mice.

Stem cells transplanted successfully in pigs

Scientists at the University of Missouri have successfully transplanted and grown stem cells in pigs, pointing the way to a similar method that could eventually be used in people.